MedTrace Logo

Treatment of Chronic Subdural Hematoma by Corticosteroids

NCT02650609 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 202

Last updated 2020-06-09

No results posted yet for this study

Summary

Chronic subdural hematomas are a frequent neurosurgical pathology in the elderly. Gold standard is surgical evacuation of these hematomas. Physiopathology of chronic subdural hematoma involves numerous inflammatory processes which could be inhibited by steroids.

Conditions

  • Chronic Subdural Hematomas

Interventions

DRUG

Methylprednisolone

DRUG

Placebo

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • Xavier XM MORANDI, MD, PhD · CHU Rennes

  • Pierre-Louis PH HENAUX, MD · CHU Rennes

  • Pierre-Jean PL LE RESTE, MD · CHU Rennes

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-24
Primary Completion
2019-03-20
Completion
2020-03-20

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02650609 on ClinicalTrials.gov